News

Chinese biotech shares are surging this year on growing optimism over innovative cancer treatments being licensed to western ...
The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.
Novartis made one of the biggest investments in Cannes among pharma companies, sending approximately 20 people from the organization to the creativity festival. They came with multiple goals, ...
A subtle ad about breast cancer self-checks led me to reflect on my own experience and the complex role of pharmaceutical companies in awareness.
Sun Pharmaceutical Industries has settled a litigation with Incyte Corporation over Leqselvi, a severe hair loss drug, in the US.
Plastics machinery M&A activity topped $900 million in the first half of 2025, led by Dover’s $624 million acquisition of ...
President Trump is pushing through with his tariff agenda, unveiling a new batch of letters to country leaders outlining ...
Anthem Biosciences Limited's ₹3,395 crore initial public offering (IPO) witnessed a subdued response on its first day, with only 0.19 times subscription by midday Monday.
Anthem Biosciences IPO opened for subscription on July 14, 2025, with a total issue size of Rs 3,395 crore via offer for sale. Priced in the Rs 540–570 band, ...
Deo circles back to the common theme at AWS. “Speed is our advantage,” he says, echoing AWS Chief Executive Matt Garman’s mantra. “We have to deliver hardware, cost controls, guardrails and creativity ...
Merck MRK recently intensified its acquisition strategy, actively pursuing deals to enhance its development pipeline and broaden its product portfolio. To build its long-term portfolio, the company ...
RIL’s stock has soared 24% this year so far against a 7% rise in the benchmark Nifty, reversing two years of underperformance ...